Newsletter Subject

Special TWK Alert: Dropping

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Wed, Oct 7, 2020 11:30 AM

Email Preheader Text

Dear Trader, The politicians in Washington have this market shook. As uncertainty rises, so does mar

Dear Trader, The politicians in Washington have this market shook. As uncertainty rises, so does market volatility. And we’re starting to see a little bit of it now. While some traders will stay cautious, I will be in full attack mode. You see, I am lasered in on the three biotech catalyst plays, which I believe, each have 5X profit potential. Given how strong these catalysts are, I’m not concerned about the market’s current choppiness, whether we rally or sell-off from here. You see, when biotech stocks have a catalyst, they can explode even when the market takes a dump… ...yesterday for example: And that is a trend that I think we’ll continue to see. Why? Because we are going to be hearing about them everywhere in the news. Think about it, we’ve got an upcoming flu season, a heap of biotech conferences, and most importantly… The Race To Find A Cure Or Treatment For Covid-19 I believe the best opportunities are in diagnostics, therapeutics, and vaccinations. My first alert, which I will be dropping very shortly, is a relatively unknown company. It’s trading in the $5-$10 range...so I believe it’s something a lot traders with small accounts can get involved in. This is a stock you will be hearing a lot about… ...the company has developed a product for Covid-19 that is a flat out game changer. It’s probably why the Department of Defense has struck a deal with them. It’s very rare you see a stock like this, trade under $10 per share… But you know what? All this market has done this year is give traders opportunities.* You better believe a good chunk of those profits came from trading biotech catalysts like the one I’m mentioning. Now if you want in on this upcoming biotech catalyst pick, [simply click here and subscribe to Trade With Kyle.]( And for a limited time,you can now join for just $299 quarterly.]( Let's do some math here. For less than $1.67 per day you get: - My Video Watchlist. Once a week, I record myself on camera flipping through charts and dissecting the markets, outlining what plays I’m eyeing and the opportunity I see in them. - Live Portfolio Stream. Want to find out how an eight-figure trader manages their portfolio in real-time? I’ll give you streaming access when you join. - Real-Time Trade Alerts: Stocks or options, it doesn’t matter, I trade them all. My alerts come with complete trading plans (entry, exit, profit target, and stop-loss) - Trading Academy: Dozens of hours of recorded training sessions. Learn my strategies at your own pace and discover how I beat the market trading biotech catalysts. And of course, my three special biotech catalyst picks, ones I believe have the most explosive upside from here. Normally I don’t open enrollment to a service with three special picks. Normally Trade With Kyle is offered annually or unlimited. But these aren’t normal times. I’m doing this for you. I want you to take advantage of the same opportunities I am. I’ve tried my best to give you a heads up in advance. However, the market waits for no one. And I don’t want any of these trades to get away from me. [Grab this offer here.]( [The first alert drops soon.]( Kyle Dennis *Results presented are not typical and may vary from person to person. Please review our full disclaimer located at ragingbull.com/disclaimer. RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at [(disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.